Corrigendum to: Increasing prevalence and incidence rates of multiple sclerosis in Kuwait (Multiple Sclerosis, (2014), 20, (543–547), 10.1177/1352458513504328);Increasing prevalence and incidence rates of multiple sclerosis in Kuwait

Multiple Sclerosis Journal

Volumn 20, Issue 5, 2014, Pages 543-547

  Alroughani, R ^a,b   Ahmed, S F ^c,d   Behbahani, R ^b,e   Khan, R ^c   Thussu, A ^a,b   Alexander, K J ^c   Ashkanani, A ^a   Nagarajan, V ^c   Al Hashel, J ^c,f  

^a AL AMIRI HOSPITAL   (Kuwait)

^b DASMAN DIABETES INSTITUTE   (Kuwait)

^c IBN SINA HOSPITAL   (Kuwait)

^d Department of Neurology and Psychiatry Al Minia Hospital   (Egypt)

^e Al Bahar Eye Center   (Kuwait)

^f KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Epidemiology; incidence; Kuwait; multiple sclerosis; prevalence

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INCIDENCE; KUWAIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION; PREVALENCE; REGISTER; SEX DIFFERENCE; SEX RATIO; HIGH RISK PATIENT; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT; AGE; EPIDEMIOLOGY; HEALTH SURVEY; RISK FACTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; KUWAIT; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; YOUNG ADULT;

EID: 84893220500     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458517716794     Document Type: Erratum

References (35)

1. Correale J, Balbuena Aguirre ME, Farez MF. Sex-specific environmental influences affecting MS development. Clin Immunol. 2013 ;:
2. Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S. Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg. 2013 ; 115: 304-308
3. Palmer AJ, Hitchens PL, Simpson S, et al. A novel method for calculating prevalence of multiple sclerosis in Australia. Mult Scler. 2013 ;:
4. Bohlega S, Inshasi J, Al Tahan AR, et al. Multiple sclerosis in the Arabian Gulf countries: A consensus statement. J Neurol. 2013 ;:
5. Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology. 2008 ; 71 (2). 129-135
6. Poser CM, Brinar VV. The accuracy of prevalence rates of multiple sclerosis: A critical review. Neuroepidemiology. 2007 ; 29 (3-4). 150-5
7. Gajofattoa A, Stefania A, Turattia M, et al. Prevalence of multiple sclerosis in Verona, Italy: An epidemiological and genetic study. Eur J Neurol. 2013 ; 20 (4). 697-703
8. Kurtzke JF. Epidemiology and etiology of multiple sclerosis. Phys Med Rehabil Clin N Am. 2005 ; 16 (2). 327-49
9. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Part 1. Acta Neurol Scand. 1975 ; 51: 110-136
10. Kurtzke JF. Epidemiologic contributions to multiple sclerosis: An overview. Neurology. 1980 ; 30: 61-79
11. Alshubaili AF, Alramzy K, Ayyad YM, Gerish Y. Epidemiology of multiple sclerosis in Kuwait: New trends in incidence and prevalence. Eur Neurol. 2005 ; 53: 125-131
12. Inshasi J, Thakre M. Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci. 2011 ; 121 (7). 393-398
13. Benamer H T S, Ahmed E S M, Al-Din A S, Grosset D G. Frequency and clinical patterns of multiple sclerosis in Arab countries: A systematic review. J Neurol Sci. 2009 ; 278: 1-4
14. Al-Din AS, Khogali M, Poser CM, et al. Epidemiology of multiple sclerosis in Arabs in Kuwait: A comparative study between Kuwaitis and Palestinians. J Neurol Sci. 1990 ; 10 (1-2). 137-141
15. Polman C H, Reingold S C, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 ; 69 (2). 292-302
16. Fries RH, Sellers TA Epidemiology for public health practice. 3 rd ed.Sudbury, MA: Jones and Bartlett Publishers, 2004: 112-121. Sudbury, MA: Jones and Bartlett Publishers ; 112-121.
17. Schoenberg BS. Calculating confidence intervals for rates and ratios. Neuroepidemiology. 1983 ; 2: 257-265
18. Deleu D, Mir D, Al Tabouki A, et al. Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler. 2012 ; 19 (6). 816-819
19. Al Jumah M, Kojan S, Al Khathaami A, et al. Familial multiple sclerosis: Does consanguinity have a role?. Mult Scler. 2011 ; 17 (4). 487-489
20. Saadatnia M, Etemadifar M, Maghzi AH. Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol. 2007 ; 9: 357-375
21. Taylor B V, Pearson J F, Clarke G, et al. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler. 2010 ; 16 (12). 1422-1431
22. Millefiorini E, Cortese A, Rezze S D, et al. The prevalence of multiple sclerosis in central Italy. Mult Scler. 2010 ; 16 (12). 1432-1436
23. El Adssi H, Debouverie M, Guillemin F. Estimating the prevalence and incidence of MS in the Lorraine region, France by the capture-recapture method. Mult Scler. 2012 ; 18 (9). 1244-50
24. Al-Araji A, Mohammed A I. Multiple sclerosis in Iraq: Does it have the same features encountered in Western countries?. J Neurol Sci. 2005 ; 234 (1-2). 67-71
25. Ammar N, Gouider-Khouja N, Hentati F. A comparative study of clinical and paramedical aspects of multiple sclerosis in Tunisia. Rev Neurol (Paris). 2006 ; 162: 729-733
26. Elhami S R, Mohammad K, Sahraian M A, Eftekhar H. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: A population-based study. Neuroepidemiology. 2011 ; 36: 141-147
27. Al-Hashel J, Besterman A, Wolfson C. The prevalence of multiple sclerosis in the Middle East. Neuroepidemiology. 2008 ; 31: 129-137
28. Celius EG, Vandvik B. Multiple sclerosis in Oslo, Norway: Prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol. 2001 ; 8: 463-469
29. Pugliatti M, Riise T, Sotgiu MA, et al. Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology. 2005 ; 25: 129-134
30. Houzen H, Niino M, Hata D, et al. Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler. 2008 ; 14: 887-892
31. Gracia F, Castillo LC, Benzadon A, et al. Prevalence and incidence of multiple sclerosis in Panama (2000-2005). Neuroepidemiology. 2009 ; 32: 287-293
32. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 ; 9 (5). 520-532
33. Simpson S, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011 ; 82 (10). 1132-1141
34. Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004 ; 3 (12). 709-718
35. Sellner J, Kraus J, Awad A, et al. The increasing incidence and prevalence of female multiple sclerosis: A critical analysis of potential environmental factors. Autoimmun Rev. 2011 ; 10: 495-502